FHL1

Chr XARXLRXLDX-linked

complement factor H

Also known as: AHUS1, AMBP1, ARMD4, ARMS1, CFHL3, FH, FHL1, HF

This gene is a member of the Regulator of Complement Activation (RCA) gene cluster and encodes a protein with twenty short consensus repeat (SCR) domains. This protein is secreted into the bloodstream and has an essential role in the regulation of complement activation, restricting this innate defense mechanism to microbial infections. Mutations in this gene have been associated with hemolytic-uremic syndrome (HUS) and chronic hypocomplementemic nephropathy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Oct 2011]

Primary Disease Associations & Inheritance

Hemophagocytic lymphohistiocytosis, familial, 1MIM #267700
AR
?Uruguay faciocardiomusculoskeletal syndromeMIM #300280
XLR
Emery-Dreifuss muscular dystrophy 6, X-linkedMIM #300696
XLR
Myopathy, X-linked, with postural muscle atrophyMIM #300696
XLR
Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onsetMIM #300717
XLD
Reducing body myopathy, X-linked 1b, with late childhood or adult onsetMIM #300718
X-linked
Scapuloperoneal myopathy, X-linked dominantMIM #300695
XLD
845
ClinVar variants
100
Pathogenic / LP
0.97
pLI score· haploinsufficient
2
Active trials
Clinical SummaryFHL1
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.97). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
100 Pathogenic / Likely Pathogenic· 195 VUS of 845 total submissions
💊
Clinical Trials
2 active or recruiting trials — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
0.28LOEUF
pLI 0.970
Z-score 3.05
OE 0.00 (0.000.28)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
0.89Z-score
OE missense 0.78 (0.670.92)
105 obs / 134.0 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.00 (0.000.28)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.0.78 (0.670.92)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.0.77
01.21.6
LoF obs/exp: 0 / 10.8Missense obs/exp: 105 / 134.0Syn Z: 1.32

ClinVar Variant Classifications

845 submitted variants in ClinVar

Classification Summary

Pathogenic78
Likely Pathogenic22
VUS195
Likely Benign115
Benign12
Conflicting13
78
Pathogenic
22
Likely Pathogenic
195
VUS
115
Likely Benign
12
Benign
13
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
28
6
44
0
78
Likely Pathogenic
6
9
7
0
22
VUS
6
168
19
2
195
Likely Benign
1
8
49
57
115
Benign
0
0
12
0
12
Conflicting
13
Total4119113159435

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

FHL1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

FHL1-related Emery-Dreifuss muscular dystrophy

definitive
Monoallelic X HemizygousLoss Of FunctionAbsent Gene Product, Altered Gene Product Structure, Decreased Gene Product Level
Dev. DisordersCardiac
G2P ↗
splice region variantstop lostmissense variantstop gained NMD escapingframeshift variant NMD escaping

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

OMIM — Genotype-Phenotype Relationships

2 OMIM entries

Hemophagocytic lymphohistiocytosis, familial, 1

MIM #267700

Disorder mapped to chromosomal region

Autosomal recessive

?Uruguay faciocardiomusculoskeletal syndrome

MIM #300280

Molecular basis of disorder known

X-linked recessive

Emery-Dreifuss muscular dystrophy 6, X-linked

MIM #300696

Molecular basis of disorder known

X-linked recessive

Myopathy, X-linked, with postural muscle atrophy

MIM #300696

Molecular basis of disorder known

X-linked recessive

Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset

MIM #300717

Molecular basis of disorder known

X-linked dominant

Reducing body myopathy, X-linked 1b, with late childhood or adult onset

MIM #300718

Molecular basis of disorder known

X-linked

Scapuloperoneal myopathy, X-linked dominant

MIM #300695

Molecular basis of disorder known

X-linked dominant
Clinical Literature
Landmark / reviewRecent case evidence